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ABSTRACT 
Introduction: 
Hospital readmissions have a great deal of public health significance, as they are burdensome 
and costly to providers, hospitals, and patients. The quality-of-care provided by hospitals is 
evaluated by comparing hospital readmission rates to national averages. Underperforming 
hospitals are penalized by the Centers for Medicare & Medicaid Services (CMS). In 2018, 2,597 
hospitals are being penalized a total of $564 million. Published studies have demonstrated a 
multitude of approaches that were successful in reducing readmission rates, but they are too 
expensive for systemic implementation within a hospital. The University of Pittsburgh Medical 
Center (UPMC) Mercy Hospital Clinical Analytics team has constructed a multiple logistic 
regression prediction model that scores patient risk factors in order to flag high risk patients who 
are most likely to experience readmission. 
Objectives/Aims: 
Primarily, this study aims to evaluate the accuracy with which the UPMC Mercy multiple 
logistic regression model correctly predicts readmission risk in a clinical application. Once 
validated, it is our secondary aim to initiate a discharge intervention specifically for patients who 
are flagged by the model. 
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Methods: 
The predictive logistic regression tool has been in use for slightly over one year at UPMC 
Mercy; daily reports score patients as ‘lowest’, ‘lower’, ‘medium’, ‘higher’, or ‘highest’ risk for 
readmission. Based on sample size calculations, about 200 individuals per predicted risk group 
were retrospectively recruited and followed for the next month in order measure readmission 
status over 7 days and 30 days. Chi-Square testing for independence and stratified one-sample 
proportion testing allowed for validation of the model’s accuracy. 
Results: 
Chi-square testing of independence demonstrated that not all risk quintiles had distinct mean 
readmission rates, contrary to our hypothesis. One-sample proportion testing further illustrated 
the poor fit for predicting 7-day readmission, with only 1/5 risk groups following expected mean 
rates of readmission. However, one-sample proportion analysis for 30-day readmission 
prediction resulted in 3/5 of the risk strata exhibiting similar mean rates of readmission as was 
expected, as well as a clinically relevant increasing trend across risk strata. 
Discussion: 
This multiple logistic regression model is not an accurate predictor of 7-day readmission. 
However, it appears that the model could be clinically relevant for predicting 30-day 
readmissions. The ‘highest’ risk strata displayed 36% 30-day readmission, which is 16-18% 
higher than the national average 30-day readmission rate. Though the model could benefit from 
optimization, it likely could be utilized in its current state to target high risk groups for 30-day 
readmission rather reliably. 
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1.0  INTRODUCTION 
1.1 SPECIFIC READMISSION MEASURE SUBTYPES 
In the growing body of literature, there is an increasingly diverse repertoire of readmission 
measures being deployed.1, 2 It is crucial to clearly define commonly utilized readmission 
subtypes because they do not all have the same implications in evaluating quality of care1. 
One of the most important factors to consider when evaluating a measure of readmission 
is the length of follow-up that is measured between discharge from the index admission (the 
original hospital stay) and the rehospitalization2. The most commonly utilized readmission 
follow-up intervals are 7-day/one week, 14-day/two weeks, 30-day/one month, 60-day/two 
months, and 90-day/three months2, 3. Readmission cases tend to cluster after discharge from the 
index admission; about ½ occur within 90 days; and about 1/3 occur within 30 days.2, 3 A longer 
readmission time interval can detect more instances of readmission than a shorter time interval2-5. 
However, shorter readmission windows are more likely to be directly related to the quality of 
care received during the index admission2-5.  
Occasionally, studies distinguish planned and unplanned readmission measures6-9. This 
readmission subtype stems from the concept of the planned readmission, in which a readmission 
is scheduled prior to a procedure7, 9. When utilizing this metric, researchers attempt to remove 
planned readmissions from their dataset, as they are not reflective of care received and are not 
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preventable7-9. For example, one vascular surgery report documented a planned readmission rate 
of 21.5%, demonstrating that studies overlooking planned readmissions can significantly 
overattribute readmission rates to poor quality of the surgery9. One major challenge of the 
preventable readmission metric is reliably reaching a consensus on which readmission measures 
are considered planned, since many studies are retrospective and observational designs6-9. As an 
example, one study focused on preventable readmissions and arbitrarily defined that any 
readmission connected with obstetrical delivery, chemotherapy, or organ transplant should 
always be classified as planned, even if a certain date is not planned7.  
Another readmission subtype found widely published within the literature is referred to as 
a potentially preventable readmission (PPR), also sometimes called a discernable readmission5, 
10. As the name implies, PPRs are readmissions that are considered to have been unnecessary 
rehospitalizations that would not have occurred in the presence of proper care, discharge 
planning, or transitory planning during the index admission5, 10. When studying readmissions, 
researchers concede that there will always be a basal level of readmissions, even under the most 
ideal circumstances, which are not associated with the index admission5, 11. Many researchers 
strongly advocate for only including PPRs when considering quality of care because they avoid 
counting the basal readmissions that are not preventable11. Relatives of the PPR readmission 
subtype are the linked and unlinked readmission measures1, 12. Linking refers to an association 
with the index admission; linked readmissions are proposed to be associated with some 
substandard practice that occurred during the index admission, whereas unlinked readmissions 
are simply coincidence rehospitalizations with no connection to the index hospitalization12. 
Finally, some studies mention all-cause or hospital-wide readmission rates, whereas 
others refer to cause-specific or disease-specific readmissions rates8, 13, 14. Studying hospital-wide 
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readmission rates is advantageous because it provides a representation of trends throughout the 
entire hospital system13, 14. Studies that focus on disease-specific readmission benefit from 
understanding how readmission affects a specific stratum of patients14-16. 
1.2 READMISSION CASE DEFINITION  
Unless otherwise specified, every occurrence of ‘readmission’ within this manuscript will refer 
to hospital-wide, all-cause readmissions without risk adjustment8, 17. This measure of 
readmissions is broadly inclusive and conservative, including all recorded instances of 
readmissions regardless of whether they were planned, linked to the index admission, or deemed 
preventable8, 17. The hospital-wide all-cause readmission measure dodges the inconsistencies, 
discrepancies, and biases that arise when panels must reach a consensus opinion in classifying 
readmissions are related or not to the index admission5, 11, 18. Observational stays that were 
recorded in medical charts are treated as admissions or readmissions in this study, despite that 
the CMS does not consider observational stays as admissions19.  
As was previously mentioned, 7-day readmissions and 30-day readmissions can offer 
different information with regards to quality-of-care; 7-day readmissions are more likely to be 
linked to index cases, whereas 30-day readmissions provide a follow-up window that tracks most 
of the patient readmissions that occur1-4. Both measures are important to the research questions 
of interest, so 7-day and 30-day readmissions are both recorded and specified accordingly within 
this study.  
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1.3 READMISSIONS AND QUALITY OF CARE 
In the 1990’s many studies began associating hospital readmissions with potential substandard 
clinical quality of care11, 20, 21. One of the original studies to identify this correlation did so by 
measuring quality of care with a metric that they titled ‘readiness-for discharge’21. In this section, 
clinical staff were scored for how well patients and their families were educated and informed, 
how clinically stable the patient was upon discharge, and what follow-up medical care was 
provided post-discharge21. Patients with heart failure or diabetes who scored in the lowest 
quartile in readiness-for-discharge surveys were twice as likely to be readmitted for the same 
condition compared to those who did not score in the lowest quartile21. Two years following the 
initial study, the same group conducted a meta-analysis of sixteen different clinical quality 
studies, where quality of care was ranked as substandard, normative, or exceptional20. This 
landmark study revealed that care categorized as relatively low quality increased the odds of 
readmission by a factor of 55 when compared with care categorized as higher quality20, 22. 
Within the past decade, readmissions have emerged as a standard method of evaluating 
clinical quality of care11, 18, 23-28.Unlike many measures, readmission statistics concentrate on 
patients at their highest vulnerability, who are attempting to transition from inpatient care back to 
a healthy lifestyle5. Though readmissions can arise naturally through unavoidable, natural 
sequalae of disease or patient frailty, the variability of readmissions between different hospitals 
indicates that some facilities are operating at a higher standard than others5, 29, 30. Programs have 
identified that strictly implementing aseptic protocols, educating patients prior to discharge, 
planning transitory care, focusing on medication needs, and communicating clearly with patients 
decreases readmission rates significantly7, 16, 28-30. In a trial studying the effects of nosocomial 
infections, researchers concluded that surgical site infections increase the rate of 30-day 
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readmission by about 2-5.5 times compared to patients who did not suffer from hospital acquired 
infections22.  Patients who experienced unplanned 30-day readmission were 55% more likely to 
have experienced poor quality of care during their index admission22. 
1.4 HOSPITAL READMISSION INDUCED BURDEN 
Repeated rehospitalizations are burdensome to patient recovery due to placing patients at 
heightened risk of developing adverse complications14, 23, 31. Many patients experience some 
degree of ‘post-hospital syndrome’, which is a period of increased vulnerability after discharge 
from a hospitalization resulting from increased stress, poor sleep, interrupted nutritional intake, 
and adverse drug effects14, 31, 32. A 2011 study of colon cancer patients found that patients who 
were readmitted within 30 days experienced 16% mortality compared to a 7% rate in those who 
did not experience 30-day readmission3. Another research group directly compared newly 
admitted acute ischemic stroke (AIS) patients to patients being re-hospitalized for AIS33. In this 
observational study, researchers concluded that readmitted patients had higher mean length of 
stays (LOS), mortality rates, and medical costs than index cases33. 
Hospital readmissions are incredibly costly to patients, providers, and hospitals. In one 
study that matched cases of Clostridium difficile Associated Diarrhea (C. diff) to patients who 
did not have C. diff, researchers concluded that C. diff increased patient length of stay by an 
average of 4.7 days, translating to an additional cost of about $7,28634. In another publication 
associating hospital quality and cost of stay, the authors determined that patients attending 
hospitals ranking in the highest quintile of complication rates paid an average of $2,400-$5,400 
more for their stay35. In 2013 estimates, index admissions cost patients and providers about 
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$13,100, whereas the average cost of readmission was $13,800 in addition to the cost of the 
index stay36. In 2013, the Healthcare Cost and Utilization Project (HCUP) calculated that the 
average cost of readmission for Medicaid or privately insured patients was about $3,000 more 
than the cost of the corresponding index admission36. In 2011, HCUP estimated $41.3 billion in 
direct hospital costs associated with 3.3 million adult all-cause 30-day readmission cases8. 
For Medicare covered patients, Heart Failure, pneumonia, and septicemia result in the 
three most frequent causes of 30-day readmissions, resulting in about 316,000 readmissions and 
$4.3 billion in hospital costs8. In Medicaid covered patients, the three most frequent conditions 
associated with readmissions are mood disorders, schizophrenia, and diabetes, which resulted in 
about 101,000 cases of 30-day readmission and about $839 million in hospital costs8. In privately 
insured patients, the three most common 30-day readmission cases were related to maintenance 
chemotherapy, mood disorders, or surgical or medical complications, resulting in about 63,000 
readmissions totaling $785 million in healthcare costs8. Finally, there are indirect burdens that 
readmissions cost patients, such as loss of income, loss of career/future employment, and quality 
of life factors like spending time away from family. One example is that about 1/5 of 
readmissions are at a different healthcare facility than the original hospitalization, which often 
leads to duplicate testing, unnecessary interventions, or delayed treatment and diagnosis27.  
Additionally, indirect impact readmissions can harm employers, who spend $260 billion in work 
related losses every year37, 38. Aside from readmission induced financial burdens, unplanned 
readmissions also disrupt clinical healthcare systems, unnecessarily diverting resources away 
from other patients who need medical attention6. 
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1.5 HOSPITAL READMISSIONS REDUCTIONS PROGRAM (HRRP) 
1.5.1 HRRP Aims 
At the end of every fiscal year, the Center for Medicare & Medicaid Services (CMS) financially 
reimburses hospitals for Medicare and Medicaid insured patients that received care15. It is 
estimated that the CMS spends over $17 billion annually reimbursing hospitals specifically for 
costs associated with unplanned readmissions, which is 17% of the total CMS reimbursement 
budget26, 28. Of the CMS money spent on readmissions, it is further estimated that $12 billion is 
wasted on ‘potentially preventable’ readmissions16. Some theorize that since hospitals receive the 
same amount of money for treating a readmitted patient as they do for treating an index case, 
readmissions perversely benefit hospitals financially16.  
Given this information, the Affordable Care Act (ACA) was enacted into United States 
law in 2010, which contained the blueprint for the Hospital Readmissions Reductions Program 
(HRRP), though it would not take full effect until 201215, 19, 24. The HRRP relies on evaluating 
hospitals based on readmission rates; a hospital with unusually high readmission rates likely is 
not performing the same standard of care as a hospital with low readmission rates15. The Hospital 
Readmissions Reductions Program aims to improve patient outcomes, decrease inefficient 
Medicare expenditures, and establish hospital culpability and transparency15, 19, 24.  
About 20% of Medicare beneficiaries experience 30-day hospital readmission, and about 
34% experience 90-day hospital readmission26. With regards to Medicare 30-day readmissions, 
rates range from 14% to 22% in the lowest and highest performing deciles of states respectively; 
this variation reinforcing the inconsistencies in care quality and opportunity for improvement14, 
39. Approximations posit that a reduction of only 10% of avoidable readmissions would save the 
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CMS $1 billion dollars yearly28. If all hospitals achieved the levels of the current highest 
performers, there would be $1.9 billion in annual savings30, 39 
1.5.2 HRRP Methodology 
Because of the basal level of unpreventable readmissions that potentially have nothing to do with 
the index admission or quality of care received, the HRRP initially only targeted three very 
frequent cause-specific readmission rates that the Center for Medicare & Medicaid Services 
(CMS) deemed to have high rates of preventable readmission in 2012: Acute Myocardial 
Infarction, Heart Failure, and Pneumonia5, 15. In the years since the HRRP’s inception, yearly 
revisions have added the following diseases to the cause-specific readmission rates that are 
monitored: acute exacerbation of chronic obstructive pulmonary disease, elective total hip 
arthroplasty, elective total knee arthroplasty, and coronary artery bypass graft surgery.  
Upon its ratification, the HRRP section of the ACA established that these measures 
would be measured immediately and published each fiscal year15. In theory, by risk adjusting 
hospital readmission rates and comparing them nationally, underperforming hospitals can launch 
initiatives to reduce the readmission rates16. These readmission rates are also posted publicly in 
an act of transparency from the CMS so that patients can compare hospitals based on quality of 
care before choosing one15.  
1.5.3 HRRP Financial Incentivization 
The final, and most crucial section of the HRRP is the incentive for hospitals to participate15, 19, 
24. Beginning in 2013, a hospital’s prior three years of unplanned cause-specific 30-day 
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readmission rates were risk adjusted for factors such as age and sex, and then compared 
nationally to other hospitals. In 2013, a hospital could be fined a maximum of 1% of its total 
CMS reimbursement.15 In 2014 the cap was raised to 2%, and from 2015 onwards it has been 
capped at 3%15, 19, 24. Financial incentives are essential to ensuring cooperation in efforts to 
improve national clinical quality of care16, 28. 
These calculations rely on a measure referred to as the standardized readmission ratio 
(SRR), also called the excess readmission ratio (ERR)15, 19, 24. The ERR is calculated individually 
for each cause specific readmission that the CMS chooses to track19. Essentially the ERR is a 
ratio that evaluates how a hospital is performing compared to how similar hospitals performed; 
any ratio over 1 indicates higher than expected readmission rates for that specific disease19. 
Then, these ERRs are then considered together in the total payment adjustment factor 
calculation, which determines how much a hospital is penalized (Figure 1)15, 19, 24.  
 
 
Figure 1. HRRP Payment Adjustment Calculation 
 
Payment adjustment factors (P) are hospital specific calculations19. In Figure 1, dx 
represents the disease specific readmission cohorts that the CMS monitors (AMI, COPD, HF, 
Pneumonia, CABG, and THA/TKA)15, 24. Payment dx, is the full CMS reimbursement to a 
hospital for a specific disease, prior to any assessed penalties15, 24. We can see that if a hospital 
has an excessive readmission rate, payment dx is multiplied by the ERR. However, if the ERR ≤ 
1, then the disease specific term is dropped from the calculation. When all of the disease specific 
readmission terms are summed together, the payment adjustment factor is equal to 1 minus the 
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sum of those terms. The term ‘min .03’ seen in Figure 1 signifies that if readmission terms add 
up to greater than .03, P is simply equal to 97%, representing the 3% cap on HRRP hospital 
fines15, 19, 24. Beginning in FY 2019, this formula also will weigh the case mix that a hospital 
faces, and only compare the ERR to other hospitals with a similar case mix24. This new 
stratification will adjust for socioeconomic status (SES), and ensure that hospitals are penalized 
for suboptimal quality of care rather than treating lower SES populations who are more 
vulnerable to readmission24.  
1.6 READMISSION TRENDS SINCE HRRP IMPLEMENTATION 
In a 2018 survey, 66% of interviewed hospital administrators believed that HRRP 
implementation had altered systemic efforts to reduce readmissions within their hospital40. 
However, the best way to evaluate the impact of the HRRP initiative is to observe the change in 
readmission trends since its implementation. Between 2009-2013, readmission for Medicare 
patients 65 and older dropped to 16.2% from 17.3%36. In 2013, the CMS reported that the all-
cause 30-day readmission rate, which had been fixed on 19% for five years, dropped to 
17.8%28.The observed reductions in readmission rates primarily stemmed from improvements in 
HRRP targeted diseases, which declined sharply within the first two years after the 
implementation of the HRRP40-42. Nonetheless, there was also an observed spillover effect, in 
which nontargeted readmission rates fell by about 1%25, 33, 41-43. Interestingly, Desai et al. 
describe that no change in readmissions was observed in the two-year window of public 
reporting prior to the CMS monetary penalization43. However, after the fines began, the sharp 
declines were observed43. 
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Of note, there are a few concerns that researchers and healthcare professionals are 
monitoring. First, a 34% increase of the use of observational stays occurred close in proximity to 
the onset of the HRRP program28. Similarly, in 2010 and 2011, the top 10% of hospitals with the 
biggest improvement in hospital readmission reduction were discovered to have increased their 
usage of observational stays in the same period by about 25%28. By utilizing observational stays, 
a patient is not truly admitted, so their return the hospital does not count as readmission against 
that hospital28. Another concern arises when readmission calculations lump surgery in with 
medical admissions. Unlike with medical hospitalizations, the surgical procedure and 
unavoidable surgical complications are a major risk factor for readmission10. This is 
demonstrable in that the spillover effect that was discussed previously was not observed in 
surgery patients40. Finally, policymakers are focused on monitoring hospital practices to ensure 
that readmission reductions are truly related to improvements in patient outcomes, while 
minimizing unintended consequences28. 
1.7 TRENDS IN HRRP INDUCED HOSPITAL FINES 
In the first year that fines were levied against hospitals for excess readmission rates (FY 2013), 
hospitals were fined a total of $290 million15. In FY 2018, that has climbed to 80% of hospitals 
that are being fined a total of $564 million15. Table 1 demonstrates how even a small percentage 
of reimbursement withholding can impact a large hospital system like UPMC. In FY 2013 and 
FY 2014, the UPMC hospital system was fined less than $1 million. However, by FY 2017 and 
FY 2018, UPMC is being fined close to $7 million annually. 
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Table 1. UPMC Readmission Penalties Since the Introduction of HRRP Penalizations 
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1.8 INTERVENTIONS TO REDUCE READMISSION RATES 
There are a plethora of successful programs that have reduced hospital readmission rates in the 
body of literature. These interventions generally fall into three broad categories: pre-discharge 
interventions, post-discharge interventions, and bridge interventions that act before and after 
discharge to bridge the two44.  Successful pre-discharge interventions tend to focus on 
standardized discharge procedures that act like a checklist to ensure a patient is receiving all 
pertinent information14, 18, 26, 30, 45.Other pre-discharge interventions can include improving 
nursing-to patient-ratios, focusing on patient understanding and education, or improving clear 
communication to the patient14, 46. Transitory interventions concentrate on providing outpatient 
care, education of adverse symptom monitoring, and patient resources external to the hospital18, 
33, 47, 48. Telephone check-in calls are a very simple and common successful post-discharge 
intervention that is found widespread throughout the literature46, 49. 
1.9 PREDICTIVE MODELING TO LOWER READMISSION RATES 
Despite the variety of proven intervention strategies that exists, to implement them a hospital 
must sacrifice a large, upfront financial investment in the payment of additional personnel, cost 
of training programs, and the coordination of care6, 13, 35, 50-52. Hospital administrators are faced 
with the task of minimizing readmissions and associated HRRP penalties whilst simultaneously 
maximizing patient outcomes and saving money13, 44, 53, 54. Predictive modeling allows 
researchers to identify high-risk populations and focus interventions on a specific stratum of 
patients rather than implementing them systemically1, 13, 55. 
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There are many patient risk factors that have been statistically associated with heightened 
risks of hospital readmissions. The most frequent risk factors in readmission models are age, 
gender, number of comorbidities, prior hospital/ED visits, Medicare insurance, and LOS4, 18, 47, 50, 
52, 54, 56, 57. Primary illness is a unique risk factor that can be utilized to estimate likelihood of 
readmissions; a 2013 Healthcare Cost and Utilization Project (HCUP) report on readmissions 
determined that the five highest rates of 30-day disease-specific readmissions were associated 
with sickle cell anemia (31.9%), gangrene (31.6%), hepatitis (30.9%), diseases of the white 
blood cells (30.9%), and chronic renal failure (27.4%)58. Aside from disease specific traits, SES 
is a commonly included risk factor in predictive readmissions modeling50. Patient labs were 
another frequently utilized risk factor in modeling, which included things such as hemoglobin 
counts and white blood cell counts50. Mental health conditions also were included in many of the 
readmission models, specifically including depression, anxiety, schizophrenia, and Bipolar 
Disorder among others13, 53, 59. 
Many predictive models for hospital readmission have been synthesized for the exact 
purpose of targeting high risk individuals for treatment. Kansangara et al., 2011 reviewed 26 
unique predictive readmission models from various publications, and concluded that all models 
poorly predicted high risk patients18. Zhou et al., 2016 then furthered pursued this study with the 
same analysis of predictive readmission models that were published after the Kansangara et al. 
review. After reviewing 73 models, the Zhou et al. concluded that only two models, both based 
on potentially preventable readmissions, achieved high discriminative ability in their 
predictions50. 
One of the key contributions from the Kansangara et al. systematic review is a list of 
criteria that the authors identify as the necessary components of an ideal predictive model for 
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readmissions. They describe that an optimal clinical readmission predictive model should be able 
to provide data prior to healthcare administrators and physicians prior to discharge, should 
reliably discriminate high-risk and low-risk patients, and should be adapted to the specific setting 
in which it is used18. 
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2.0  PROJECT AIMS 
Hospital readmissions are burdensome and costly to providers, hospitals, and patients; financial 
penalties and loss of beds and staff damage hospitals, loss of income and poorer prognoses 
impact patients, and the excess costs of hospital stays harm insurers. Given that no party benefits 
from readmissions, there have been numerous efforts to reduce them. However, the major 
setback in reducing readmission is determining how the interventions are employed within 
healthcare systems. Because hospitals have finite resources, interventions must focus on certain 
risk groups, comorbidities, hospital units, etc. 
To address this issue within the UPMC hospital system, UPMC clinical analytics team 
analyzed past patient data to synthesize a real-time logistic regression model that weighs patient 
traits, such as age, gender, whether a patient had experienced an admission in the past year, etc. 
The model then considers these patient traits and scores patients in risk quintiles ranging from 
‘lowest’ risk to ‘highest’ risk for future readmission. The ultimate goal of the prediction tool is to 
alert healthcare workers to which patients are the most likely to be readmitted. Nurses and 
physicians can then flag high risk patients for strategic and cost-effective discharge 
interventions. Reports with patients’ predicted readmission scores are compiled daily and 
emailed to physicians at UPMC Mercy. This system has been active within UPMC Mercy for 
slightly over one year. Unfortunately, the validity of the model’s predictions remains unknown, 
so it is not utilized routinely as a diagnostic tool like it was intended to be. 
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Our primary aim within this study is to analyze the accuracy of this clinical prediction 
model and to validate this instrument for reliable usage in clinical care. In the primary step, we 
aim to ensure that individuals across risk quintiles have distinct patterns of readmission. We 
hypothesize that the five risk quintiles to which patients are assigned will exhibit statistically 
different mean 7 and 30-day readmission rates from each other. Second, we aim to compare the 
model’s predicted mean readmission rates to the observed mean readmission rates for each 
assigned risk group within our cohort. We hypothesize that none of the five assigned risk groups 
will have significantly different observed and expected 7-day or 30-day mean readmission rates. 
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3.0  METHODS 
 
Figure 2. Experimental Design Flowchart 
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3.1 MULTIPLE LOGISTIC REGRESSION 
3.1.1 Introduction to Logistic Regression 
 
 
Figure 3. Logistic Regression Calculations 
 
Multiple logistic regression is an integral analytic technique, used to estimate the 
probability that a binary event will occur based on weighing multiple covariates or risk factors. 
Figure 3 details the various formulae that are associated with logistic regression. Figure 3A 
displays how the log probability ( ), referred to as ‘logitP’, is calculated. β0 is the y 
intercept, and broadly can be interpreted as the log odds of the binary outcome when none of the 
risk factors are present, though exceptions to this interpretation arise when a risk factor is 
continuous (i.e. age of 0 isn’t really possible). There are k variables/risk factors that are included 
in a multiple logistic regression model. Xj represents each variable value that is factored into the 
model, and βj is the associated coefficient for each variable. Based on all of the terms described 
thus far, Figure 3A for LogitP can be rewritten more simply as  in which each 
individual risk factor is associated with its own  term. The sum of all k risk factor terms and 
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the y intercept then provides the estimated logitP. Once all of the risk terms and the intercept are 
summed, the logitP can be transformed into a probability through the equation detailed in Figure 
3B. If the logitP value is calculated in part 1A, it can be substituted into exponential term that’s 
in Figure 1B, such that: p(x) =  .  
3.1.2 Accounting for Various Variable Types 
 can take on a different meaning based on the type of variable that x codes for. When 
considering nominal categorical variables, such whether a patient has diabetes (Y/N), it is 
standard practice to code ‘1’ for yes and ‘0’ for no. If the patient has diabetes, the term 
 is included in the model, and the term will equal the beta coefficient for diabetes. 
However, if the patient does not have diabetes, the term  would be included in the 
model, cancelling out the diabetes term in this calculation. When x is a continuous variable, such 
as age, x simply will equal the patient’s age. If a patient’s age is 50 years old, the age term will 
be . Finally, there are situations in which ordinal variables are considered, like with 
systolic blood pressure ranges:  
<120mmHg = normal 
 120-129mmHg = elevated,  
130-139mmHg = stage 1 hypertension,  
>140mmHg = stage 2 hypertension.  
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It would be standard practice in this example to code normal blood pressure as ‘0’, 
elevated as ‘1’, stage 1 hypertension as ‘2’, and ‘stage 2 hypertension as ‘3’. When 
(  ) is then calculated for a patient who falls within normal range of blood 
pressure, (0 *  ) drops the term from the model. When  takes on the other 
potential values (In the blood pressure example 1,2, or 3),  simply compounds by each 
additional level of ordinality. 
3.1.3 Creation of the Readmission Multiple Logistic Regression Model 
Within the context of the current study, the binary outcome of interest is whether or not a patient 
is readmitted during the follow-up time of 7 or 30 days. The UPMC clinical analytics team 
initially considered over 100 covariates within univariate analyses that were based on forest plots 
synthesized from systematic review of readmission literature. These covariates were evaluated 
for significance within a training dataset of 1,000,000 prior UPMC patients. Variables that were 
statistically significant within the univariate analyses were then considered for multiple logistic 
regression. Covariates found to be significant in the multiple logistic regression analysis then 
were analyzed for multicollinearity, and were combined or dropped from the model if covariates 
were significantly related with each other. This final model had strong specificity, sensitivity, 
and c-statistic scores.  
Unfortunately, many of the covariates considered in this regression model were extracted 
from patient labs, diagnostic factors, and complications that were not added to the patient’s chart 
for at least 3 days post-discharge. For example, the literature states that about 30% of patients 
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admitted for Sickle Cell Anemia are readmitted within 30 days, and the initial regression model 
found that it was a very reliable predictor of readmission58. However, blood cultures are not 
analyzed and added to the EPIC electronic medical records until at least 3 days post-admission, 
and sometimes one-week post-admission. Though many of these covariates that were dropped 
increased the validity and reliability of the logistic regression model’s predictions, the model 
itself is not clinically useful if scores cannot be obtained until after a patient is discharged. Due 
to this, the UPMC clinical analytics team dropped all of the covariates that would not be 
available during the first 24 hours of a patient’s index admission from the final multiple logistic 
regression model. 
3.2 SAMPLE SIZE CALCULATIONS 
Following standard practices, it was determined that our type I error would be held fixed at 5%. 
In order to minimize the risk of type II error, the number of participants needed per risk group 
was calculated based on 80% power. Because sample size calculations are dependent on the 
primary outcome analysis, the aforementioned calculations were based on the one-sample 
proportion testing. Single proportion sample size calculations were based on the formula:  
n ≥  
n = the number of people needed per group 
M = Margin of error 
 = Estimated probability of readmission 
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However, the expected proportion of readmissions is not consistent across risk strata. 
Because the  term is mathematically maximized with a value of 0.5, all sample size 
calculations conservatively set the likelihood of readmission under the null hypothesis to 50%. 
3.3 STUDY DESIGN AND ENROLLMENT 
At the onset of this study, the logistic regression tool had predicted patient readmission risks at 
UPMC Mercy for slightly over one year. This type of data lends itself to a retrospective cohort 
design. Because the model’s past predictions were made in real-time and recorded in a 
spreadsheet, the quality of the predictions could be evaluated by searching those patients’ 
Electronic Medical Records (EMRs) to determine if patients were actually readmitted within 7 or 
30-days. Figure 4 details both the study design and the timeline. 
 
 
Figure 4. Retrospective Cohort Design and Timeline 
 
Based on the sample size calculations, it was determined that about one month of logistic 
regression predictions would suffice to ensure the appropriate study power. Because the study 
 24 
began in July 2018, predictions from the most recent month with a full 30-days of follow-up time 
were recruited and analyzed. 
3.4 STATISTICAL ANALYSES 
All analyses were conducted with a fixed alpha of .05 in order to minimize the risk of Type I 
error. Calculated p-values were then directly compared to this fixed alpha value to determine 
significance. All statistical tests were calculated using Stata SE 14 or SAS 9.4. 
3.4.1 Demographic Analysis 
Demographic analysis was necessary to ensure that the recruited sample population did not 
significantly differ from the 25,000-person training set. It is worth noting that since age and sex 
are weighted in the model, they cannot be adjusted for if significant differences exist in the 
testing population and the actual patient population. Nonetheless, it is absolutely crucial to carry 
out demographic analysis to ensure that the training set mirrors the demographics of the patients 
in this study. Otherwise the model’s coefficients will be tailored to a different population, and 
the predictions will not be accurate. Age, sex, and length of stay were compared between 
predicted risk groups. All continuous means were tested for significance with ANOVA, and all 
categorical hypothesis testing relied on chi-square analysis. 
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3.4.2 Chi-Square Analysis 
Chi-square testing is essential in determining that the predicted risk groups actually experience 
distinct mean proportions of readmission. Initial chi-square analysis tested the alternative 
hypothesis that at least one risk group was distinct from the others: 
 
H0: plowest = plower = pmedium = phigher = phighest 
H1: At least one risk group’s mean proportion of readmission is significantly different 
from    
the other risk groups’ mean proportions of readmission. 
 
Testing were conducted independently for 7-day and 30-day readmission. The initial chi-
square tests were followed by post-hoc testing, utilizing pairwise comparisons to identify which 
risk groups were and were not significantly distinct from each other. Because pairwise tests rely 
on multiple comparisons, adjustments must be made to make α more conservative. While 
Bonferroni tests are often a strong adjustment tool for multiple comparisons, it is not an 
appropriate technique in this scenario. Bonferroni adjustments divide the α value by the number 
of pairwise comparisons. Because our analysis includes all ten pairwise comparisons, the alpha 
value considered for rejection would be 0.005, which is overly conservative in this context. A 
Tukey’s adjustment for multiple comparisons is a more appropriate statistical technique for this 
analysis, because all pairwise tests are considered in a single step and control for standard error 
between mean proportion rates. All crude p-values and Tukey adjusted p-values are provided in 
the χ2 results section so that the effect of the adjustment is visible. 
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3.4.3 One-Sample Proportion Testing 
When the multiple logistic regression model was applied to the 25,000-person dataset of past 
UPMC Mercy patients, mean proportion rates of 7 and 30-day readmission were calculated for 
each stratified risk group. Each risk group’s mean proportion of readmission was utilized as an 
expected rate in a one-sample proportion test. Hypothesis testing was conducted at 7-days and 
30-days: 
 
H0: pKobs = pKexp 
H1: pKobs ≠ pKexp 
 
In this testing, k designates the kth risk group. In this study, k will be one of the 
following: lowest, lower, medium, higher, or highest. Obs represents the observed mean 
proportion for the kth stratum in our retrospective cohort, while exp designates the expected 
proportion of readmission based on the training dataset. Testing concluded whether or not 
observed stratum specific mean proportion rates of 7 and 30-day readmission significantly 
differed from the expected stratum specific mean proportion readmission rates. 
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4.0  RESULTS 
4.1 LOGISTIC REGRESSION MODEL 
Patient predictions for likelihood of readmission were calculated from covariate coefficients and 
p-values that are listed in Figure 5A. As is observable from Figure 5A, a patient having 
experienced a hospital admission within the previous year is by far the largest predictor of 
readmission within the context of this model; so much so that there are two separate equations 
with different coefficients depending on whether a patient was or was not readmitted within the 
past year. Aside from prior admissions, low SES population (Lpop: yes/no) was another 
covariate that explained a large proportion of readmission predictions. If not admitted within the 
past year, patients who are from low SES population experience 2.06 times greater odds of 
experiencing readmission compared to those who are not low SES population and were not 
readmitted in the past year. If patients were admitted within the past year, being of low SES 
makes them 1.55 times more likely to be readmitted compared to those who are not low SES. 
Other significant risk factors included within the model were age, gender, whether a patient was 
transferred from a skilled nursing facility (SNF), whether a patient was a transfer from another 
hospital, if a patient had visited the emergency department within the past year, and if the patient 
carried Medicare insurance (commercial rollup). The category titled Transformed Previous 
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Hospital Visit, indicates that the readmission is directly related to the prior hospital visit, which 
is why it is only applicable to the model in which a prior hospital visit had occurred. 
Because patient charts are maintained in an electronic medical record (EMR), XJ patient risk 
factors from Figure 5A are automatically collected from patient charts via the logistic regression 
tool. In this sense, the tool creates patient readmission risk scores in real-time based on passively 
collected data from patient charts. Instead of directly being quantified as a probability of 
readmission, the calculated logitP probability is translated into categorical risk quintiles: Lowest, 
Lower, Medium, Higher, and Highest risks. In order to determine the cutoffs for the quintiles, 
data researchers on the UPMC Clinical Analytics team rigorously conducted and calculated 
analyses of sensitivity, specificity, ROC curves, c statistics, and confusion matrices to maximize 
accuracy of the model. Of particular note, this team trained the model to more accurately predict 
readmissions in the highest and lowest quintiles, since the extremes were of highest interest for 
clinical application. 
Figure 5C demonstrates the final cutoffs that were set in order to transform a calculated 
logitP into a risk score. These cutoffs were tested for accuracy within a 25,000 person test dataset 
of past UPMC Mercy patients that is pictured in Figure 5B, and quantified in 5C. From the 
graphical data in Figure 5B, it is evident that not all quintiles share an equal range; the ‘lower’ 
(quintile 2) has very narrow range, especially in comparison to the ‘highest’ (quintile 5) risk 
group, which ranges across more than half of the chart. As was expected, readmission rates 
amplified respectively across increasing risk quintiles (Supplemental Table 1).  
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Figure 5. Multiple Logistic Regression Model and Cutoffs Utilized to Make Readmission Predictions 
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4.2 SAMPLE SIZE CALCULATIONS 
Because the testing dataset confirmed that the model was accurate under ideal conditions, the 
next step was to test the real-time accuracy of the model in a clinical setting. In order to approach 
this research question, sample size calculations were performed first at 80% power and 5% type I 
error. These were calculated for the primary outcome of interest, the one-sample proportion tests:  
H0: pexp = pobs 
H1: pexp ≠ pobs 
 
Figure 6A highlights an ideal sample size of recruiting 800 people per risk quintile, 
which would allow a ≥ 5.5% difference in expected and observed readmission rate to reject the 
null hypothesis. For this initial proof of concept study, we include 200 people per risk group, 
yielding a minimum rejectable difference between expected and observed of slightly under 10% 
(Figure 6B). While not as reliable of a range, it is worth noting that these projections are 
conservative. Figures 6A and 6B were calculated under the null hypothesis of pexp = 50%, which 
maximizes the number of people needed. In reality, no expected readmission rate was 50%, and 
most were around 15-20%, so these are conservative estimates to power the study. Figure 6C 
demonstrates this concept by putting different null hypotheses on the x-axis to display how the 
minimum detectable difference changes with n fixed at 200 people per group. 
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Figure 6. Minimum Detectable Difference and Sample Size Calculations 
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4.3 DEMOGRAPHIC ANALYSIS 
Given that 200 people per risk group was the targeted sample size, a window of predictions that 
were made between April 7, 2018 and May 30, 2018 was chosen, consisting of 1,192 total 
patient predictions. Unfortunately, about 350 recruited individuals were censored prior to 
analysis due to duplicate predictions, missing patient information, and because some admissions 
were actually internal ‘step-down’ transfers without a true discharge. In the actual analyzed 
dataset, 858 patients remained, with only one risk group containing 200 patients. However, 
because the sample size calculations were overly conservative and that this was a proof of 
concept study, it was determined that the cohort was still of a sufficient sample size to continue 
onwards. After patient data was sorted from this time period, a brief demographic analysis was 
considered. It is important to note that no stratification can occur, because the logistic regression 
is already weighing these covariates. However, it still is very important to observe trends in 
covariates so that potential anomalies can be explained. 
 
Table 2. Demographic Analysis By Risk Group Assignment 
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Table 2 provides a cursory demographic analysis amongst the predicted readmission 
quintiles. Gender, age, and length of stay were all determined to be very significantly different 
across risk strata. The most glaring contributor to this observation is that 94.4% of the lowest risk 
strata consisted of male patients, which is highly unexpected. Supplemental Table 2 includes 
post-hoc ANOVA testing for LOS. Interestingly, all pairwise comparisons of the medium group 
had some level of significance. Supplemental Table 3 displays post-hoc ANOVA testing for 
Age, in which there are many significant pairwise comparisons. Simply looking at the trend 
however, the lowest risk strata has the highest mean age, and the medium risk strata has the 
lowest mean age, which again is unexpected.  
4.4  χ2 TESTING FOR INDEPENDENCE 
The initial analysis intended to test if the assigned risk groups truly had distinct readmission rates 
from each other. Clinically, this test is incredibly important because if two risk groups 
experience overlapping mean readmission rates, then the predicted quintiles are not clinically 
useful for implementing interventions. First, a χ2 test of independence was conducted separately 
for 7-day and 30-day readmissions: 
 
H0: p1 = p2 = p3 = p4 = p5 
H1: At least one risk quintile has a different mean proportion of readmission 
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Table 3.   χ2 Testing for Independence of Readmission Rates 
 
As was hypothesized, Table 3 strongly favors the alternative hypothesis that for both 7-
day and 30-day readmissions, at least one risk group experienced different rates of readmission 
than the rest. 
Next, post-hoc analysis was conducted for 7-day readmissions. Crude p-values and 
Tukey adjustments for multiple comparisons are both shown in Table 4.  
 
Table 4. 7-day Readmission χ2 Post-Hoc Analysis 
 
 
Table 4 disputes hypotheses that all groups are distinct from one another, rather 
suggesting the opposite. When considering the adjustments for multiple comparisons, there are 
only 2/10 (20%) comparisons that are significantly different in mean 7-day readmission rates, 
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which both involved the ‘highest’ risk group. This suggests that the model is not an accurate 
predictor of 7-day readmission rates. 
Following this analysis, 30-day readmission post-hoc χ2 analysis was considered. Table 5 
demonstrates that the logistic regression model was much more accurate in predicting 30-day 
readmission, though still not all groups are distinct as was hypothesized. In Table 5, 5/10 (50%) 
head-to-head comparisons resulted in discrete mean rates of 30-day readmission. In examining 
which head-to-head comparisons are statistically significant, it is clear that the ‘lowest’ and 
‘highest’ strata both overlap with other risk groups but remain distinct from each other as would 
be expected. 
 
Table 5. 30-day Readmission χ2 Post-Hoc Analysis 
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4.5 ONE-SAMPLE PROPORTION TESTS 
Finally, one-sample proportion tests were conducted to assess how accurately the model’s 
predictions followed patterns observed from the 25,000-person test dataset: 
 
H0: pExp = pObs 
H1: pExp ≠ pObs 
 
All expected mean readmission rates originate from analysis of the test dataset, which are 
chronicled in Supplemental Table 1. 
First, observed 7-day readmission rates were compared to expected 7-day readmission 
rates. Table 6 demonstrates again that the logistic regression model is a poor predictor of 7-day 
readmission. Only the ‘lowest’ risk group did not show a statistically different rate of observed 
and expected readmission. Moreover, what is alarming about Table 6 is that observed 
readmission does not follow an increasing trend across higher strata, further highlighting that the 
7-day risk groups do not have statistical or clinical significance. However, one positive aspect of 
Table 6 is the observed rate of the ‘highest’ risk group. Though not statistically similar to the 
expected mean rate of readmission, the ‘highest’ risk group still displayed a markedly higher 
mean rate of 7-day readmission than the other risk quintiles. From a clinical perspective, it is 
encouraging that the model can correctly predict the highest risk group for 7-day readmissions. 
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Table 6. 7-day Readmission One-Sample Hypothesis Test of Proportions 
 
Next, 30-day expected and observed readmissions were compared to each other. Table 7 
reinforces that the 30-day risk group predictions have much higher accuracy than the 7-day 
predictions. Statistically, the observed ‘lowest’, ‘lower’, and ‘higher’ risk strata are not 
significantly different from the expected rates of 30-day readmission. More encouragingly, there 
is high clinical relevance present here; observed 30-day readmissions increase across strata in an 
expected pattern with the exception of the ‘medium’ risk group. For example, the observed 
‘highest’ risk group has a significantly different mean 30-day readmission from the expected 
value. However, clinically 36% is by far the highest observed readmission rate across all strata, 
and is much higher than the average rate of readmission. In this sense, the logistic regression 
model provides clinically useful predictions in regard to 30-day readmissions. 
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Table 7. 30-day Readmission One-Sample Hypothesis Test of Proportions 
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5.0  DISCUSSION 
5.1 CONCLUSIONS 
In a readmission prediction modeling validation study amongst patients at UPMC Mercy who 
were admitted between April 7 – May 3, 2018, we found mixed results with regards to the 
accuracy of the logistic regression readmission prediction tool. We hypothesized that this tool 
would successfully assign risk predictions such that increasing risk quintiles would experience 
increasing and distinct rates of 7-day and 30-day readmission. We also hypothesized that the risk 
quintiles in the retrospective cohort would experience similar mean rates of 7-day and 30-day 
readmission to the mean rates of readmission from the training dataset. 
Sample size calculations determined that for a pilot study such as this, recruiting about 
200 people per risk group would conservatively provide enough people to power the study at 
80%, with a minimum detectable difference slightly below 10%. Patients who were admitted at 
UPMC Mercy Hospital between April 7, 2018 and May 30, 2018 were recruited to the study. 
Though seasonal variability in hospital visits could explain a small portion of the variation that 
exists within this study, it would be a source of nondifferential bias across the risk groups. 
Furthermore, it would not legitimately explain some of the extreme and unexpected observations 
such as the high male percentage in the ‘lowest risk group’ or the very low rates of readmissions 
within the ‘medium’ risk group. 
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Chi-square analyses of independence were conducted to test if the different risk quintiles 
experienced different mean rates of readmission from each other. When it was confirmed that the 
quintiles did have at least one risk group with different 7-day and 30-day readmissions from the 
others, pairwise post-hoc testing was considered. 7-day readmission post-hoc testing determined 
that there was a large amount of overlap in mean readmission rates amongst risk groups, with 
only 20% of comparisons showing a significantly different rate of readmission. When 30-day 
readmission underwent post-hoc chi-square testing, more groups were significantly distinct, 
though half of comparisons still overlapped with each other. 
Finally, one-sample proportion tests were conducted for each individual stratum to 
compare expected rates of readmission from the training dataset and observed rates of 
readmission within this cohort. When 7-day readmissions were analyzed, only one risk quintile 
exhibited similar characteristics as the training dataset, further demonstrating that the model is 
not accurate when predicting 7-day readmissions. However, analysis of 30-day readmissions 
displayed mixed results. Statistically, only 60% of the quintiles followed readmission rates that 
were similar to the expected rates of readmission, which is still less than ideal. Nonetheless, 30-
day readmission rates increased across risk groups as would be expected, with exception of the 
‘medium’ risk group. 
The multiple logistic regression model certainly did not perform to hypothesized 
expectations, and would likely benefit from another round of analyses that tweak the value of the 
beta coefficients and the cutoffs between quintiles. It is significant to note that when setting the 
cutoffs for the risk groups, the UPMC clinical analytics team concluded that there was high 
sensitivity and specificity for both the model’s 7-day and 30-day readmission predictions. Before 
moving forward with the model, it is very important to understand why the model was accurate 
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with its 7-day readmission predictions in the training dataset, but not in our cohort. It is plausible 
that 7-day readmission is more variable than 30-day readmission because it involves a smaller 
follow-up time. Like with all statistics, as the sample size increases, the variation within the 
observations narrow. So, as the follow-up time increases, it is more likely that a study will detect 
more reliable mean rates of readmission.  
The model in its current state clearly identifies the ‘highest’ risk group for both 7-day and 
30-day readmissions. Because the intended purpose of the model is to target the highest risk 
patients for intervention, it may not be necessary to improve the accuracy of the model within 
lower risk groups. In its current iteration, these analyses support that the predictive model can 
effectively target the highest risk populations. 
5.2 LIMITATIONS & POTENTIAL SOURCES OF BIASES 
One potential source of bias is the discrepancies that may arise between the model and human 
data entry. Misclassification of outcome could affect the data here, because data entry may score 
readmissions differently than the model. For example, data entry could rate an internal transfer 
across UPMC as no readmission, whereas the model may score that as discharge and 
readmission on the same day. Another example could be different scoring of observational stays. 
Data entry was not checked by a panel, so it is also subject to human error. 
Another limitation of the study could result from different hospitals treating the same 
patient. Studies have documented that between 20-40% of readmission occur at a different 
hospital from the index case16, 20, 26, 27. Additionally, if patients feel they received suboptimal care 
during an index admission, they will likely seek a different hospital upon readmision27. Hospitals 
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are only capable of tracking readmissions back to themselves, so there is likely a differential 
underestimate of readmission rates within this study27. However, because there are only two 
major healthcare systems in the greater Pittsburgh area, it is likely that it this underestimation is 
mild. 
The demographic table provides a look at a few troubling sources of bias in our study. 
The medium risk group in our study consistently exhibited the lowest rate of 7-day and 30-day 
readmission. In the demographic analysis, the medium risk group also had the lowest male 
population percentage, shortest length of stay average, and youngest average age. It is worth 
further investigating why this occurred, and if it contributed to any introduction of bias. 
One final source of bias could be an existing intervention effort at UPMC Mercy. There 
was a belief among some clinical and analytics professionals that people belonging to the lowest 
risk group did not need any special attention, and that those in the highest risk group were too 
unlikely to actually improve. With that methodology, a transitory care intervention was begun at 
UPMC Mercy that focused on patients identified as medium risk. Though further analysis needs 
to be conducted, a successful intervention effort potentially is what caused to the unexplained 
low trends in readmission rates in the medium risk group that is observed throughout the entirety 
of this study. 
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5.3 FUTURE DIRECTIONS 
5.3.1 Potential Ways to Improve Model Accuracy 
In order to improve the accuracy of the model, the first ideal step would be to continue recruiting 
more participants to the current study. The training dataset enrolled 25,000 patients in 
comparison to our 858 patients enrolled. There is a high likelihood that as we continue to add 
patients to the current trial, we would begin to normalize on the true mean readmission rates that 
are closer to the rates observed in the training dataset. Additionally, instead of relying on 
arbitrary cutpoint categorizations, it likely could be beneficial to conduct similar analyses that 
classify patients based on their exact continuous P(x) likelihoods for readmission. 
The other potential way to improve the model would be to consider nontraditional risk 
factors in univariate and multivariate analyses. Both Kansangara et al. and Zhou et al. performed 
systematic reviews to characterize successful predictive models for readmission and found very 
limited success with very similar risk factors considered in each model, similar to what was 
utilized in our own model18, 42, 50. They suggest that overlooked aspects such as health literacy, 
family support, and availability of transportation can be combined with traditional measures such 
as LOS to generate a more accurate representation of predictive health18. 
5.3.2 Discharge Intervention Experimental Design 
The next step in this study is to link specific transitory discharge interventions with predicted 
risk groups. This study can be completed in two different ways, which are both outlined in 
Figure 7. The most ideal scenario would be to conduct a randomized controlled trial (RCT), in 
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which patients within the same strata are matched for confounding risk factors, and then 
randomized to receive standard discharge protocols or the intervention discharge procedures. 
Following 30-days post-discharge, the 7-day and 30-day readmission rates can be calculated and 
analyzed. With this experimental design, the differences in readmissions rates across strata can 
be attributed to the intervention, allowing researchers to determine which readmission risk group 
intervention efforts benefit the most. If the resources are not available to conduct an RCT, a very 
similar analysis is detailed in Figure 4 utilizing a prospective cohort design.   
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Figure 7. Future Discharge Intervention Experiment 
 
 
 
 
 46 
6.0  PUBLIC HEALTH IMPACT 
Readmissions are burdensome to patients, providers, and hospitals. Because hospital resources 
are limited, any model that can target high risk individuals is beneficial to public health 
outcomes. Frequent readmissions can be deleterious to a patient, causing a post-hospital 
syndrome in patients that results in heightened vulnerability for adverse outcomes, stemming 
from sleeplessness, anxiety, and stress associated with hospital admissions. Furthermore, the 
average cost of an admission is $13,100. But, the average cost of a readmission is $13,800 in 
addition to the cost of the index stay, which can further add stress and vulnerability to a patient.  
Numerous interventions have demonstrated marked decreases in readmissions rates, but 
in most instances hospitals do not have the staffing resources to carry out discharge interventions 
systemically. Due to this, an accurate model that can target high risk patients would very likely 
improve patient outcomes and reduce readmission rates. Our prediction model specifically 
operates in real-time, which provides it a genuine opportunity to be utilized as a diagnostic tool. 
Since the intention of the prediction model is to aid decisions prior to patient discharge, a flagged 
high-risk patient can receive heightened patient education, medication reviews, planned 
transitory care, and communication with a healthcare professional.  
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APPENDIX:  SUPPLEMENTAL TABLES 
Supplementary Table 1. Readmission Rates from Test Dataset 
 
 
Supplementary Table 2. LOS Demographics ANOVA Post-Hoc Testing 
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Supplementary Table 3. Age Demographics ANOVA Post-Hoc Testing 
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